AzTrials
AzTrials

OtosclerosisNCT06323863

Ultra-high Resolution CT: the End of Stapes Prosthesis Measurement Misestimation

An observational study of Otosclerosis, run by Central Hospital, Nancy, France at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Actual CT scanners overestimate stapes piston size, and do not represent a valuable technique for their follow-up, especially in case of complication. Ultra-high resolution has not yet been evaluated in this setting. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Otosclerosis
What is being tested?
stapedectomy and ultra high resolution CT
Type of treatment
Surgery or procedure
How many people
20 participants
Where
1 siteFrance
Study dates
1 Apr 2024to 1 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients with otosclerosis who underwent stapes replacement by a prosthesis and underwent ultra high resolution CT for follow-up

Who may be able to join

  • stapes prosthesis Ultra-high resolution CT available

Who cannot join

  • no materiovigilance report available

Trial locations and contacts

1 site in 1 country.

romain gillet, md contact

00.33680987216

r.gillet@chru-nancy.fr

France1 site
  • Chu Nancy

    Nancy, 54000

    romain gillet, md, 00383851811, r.gillet@chru-nancy.fr

Other trials in France

About this study

Actual CT scanners overestimate stapes piston size, and do not represent a valuable technique for their follow-up, especially in case of complication. Ultra-high resolution has not yet been evaluated in this setting.

Read the detailed description

Modern temporal bone imaging systems, using 0.5 mm slice thickness, are reputed not yet able to depict the stapes piston position with a sufficient degree of accuracy, as high-resolution CT measurements consistently overestimated intravestibular piston dimensions (width by 44%, length by 6.25%) and vestibular intrusion (by 39%) because of metallic artifacts. . The exact limits of intravestibular depth are also unclear. The "safe" intravestibular prosthesis depth varies widely between studies and has been reported to range from 0.2 to 2.5 mm, so 39% may represent up to 0.9 mm of misestimation. Ultra-high resolution CT (UHR-CT) has improved spatial resolution to 0.12 mm by using ultra-small detector elements (0.25 x 0.25 mm), allowing better visualization of temporal bone structures compared to high-resolution temporal bone CT (HR-CT). However, this technique has not been described for stapes prosthesis measurement.

Conditions
Otosclerosis
Being tested
stapedectomy, ultra high resolution CT
Keywords
stapes, titanium, computed tomography
Medical subject headings
Otosclerosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • stapedectomyProcedure or surgery

    stapes removal and replacement by a prosthesis

  • ultra high resolution CTRadiation

    imaging study

Study groups in NCT06323863
Study groupRoleWhat they receive
patients who underwent stapes surgery at our instutionpatients with otosclerosis who underwent stapedectomy in our institution
Receives: Procedure: stapedectomy; Radiation: ultra high resolution CT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. length

    length of the prosthesis on CT

    Measured: february 2020 - novembre 2023

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2024
  2. Study start1 Apr 2024 (estimated)
  3. Primary completion1 Jun 2024 (estimated)
  4. Study completion1 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06323863
Sponsor's protocol ID
N°4-RCB/EUDRACT
Status last verified
Nov 2023
First submitted
15 Mar 2024
Last updated
21 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: because CT-scanner are the patient's proprety

Publications

  • Bozzato A, Struffert T, Hertel V, Iro H, Hornung J. Analysis of the accuracy of high-resolution computed tomography techniques for the measurement of stapes prostheses. Eur Radiol. 2010 Mar;20(3):566-71. doi: 10.1007/s00330-009-1582-4. Epub 2009 Sep 2.

    PubMed 19727746
  • Fang Y, Wang B, Galvin JJ 3rd, Tao D, Deng R, Ou X, Liu Y, Dai P, Sha Y, Zhang T, Chen B. MPR-CT Imaging for Stapes Prosthesis: Accuracy and Clinical Significance. Otol Neurotol. 2016 Apr;37(4):321-3. doi: 10.1097/MAO.0000000000000987.

    PubMed 26927761
  • Gil Mun S, Scheffner E, Muller S, Mittmann P, Rademacher G, Mutze S, Wilms K, Boga E, Bjorn Gehl H, Sudhoff H, Todt I. Stapes piston insertion depth and clinical correlations. Acta Otolaryngol. 2019 Oct;139(10):829-832. doi: 10.1080/00016489.2019.1637019. Epub 2019 Jul 12.

    PubMed 31298596

Questions about this trial

What is this clinical trial studying?

An observational study of Otosclerosis, run by Central Hospital, Nancy, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact romain gillet, md (00.33680987216, r.gillet@chru-nancy.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

length (time frame: february 2020 - novembre 2023). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06323863, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in